| Financial Year |
March 31 2023 |
| Monetary Funds |
1,381,545,911.18 |
| Held-for-trading Financial Assets |
1,192,484.22 |
| Notes Receivable |
8,787,500.00 |
| Accounts Receivable |
577,475,276.07 |
| Advances to Suppliers |
203,806,486.06 |
| Other Receivables |
21,991,636.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
300,904,952.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,425,795.49 |
| Total Current Assets |
2,676,170,043.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
56,375,233.13 |
| Investment Properties |
6,275,352.00 |
| Fixed Assetes |
848,066,952.12 |
| Under-construction Projects |
385,837,174.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
331,734,156.82 |
| R&D expenses |
-- |
| Goodwill |
448,906,666.06 |
| Long-Term Deferred and Prepaid Expenses |
10,727,053.30 |
| Deferred Income Tax Assets |
47,768,638.42 |
| Other Non-Current Assets |
36,836,173.25 |
| Sub-Total of Non-Current Assets |
2,182,748,418.61 |
| Total Assets |
4,858,918,462.33 |
| Short-Term Loans |
699,311,634.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
48,916,506.45 |
| Accounts Payable |
294,297,361.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,988,019.73 |
| Taxes Payable |
52,334,286.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,113,647.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,543,337.37 |
| Other Current Liabilities |
68,274,411.78 |
| Sub-Total of Current Liabilities |
1,792,537,745.83 |
| Long-term Loans |
100,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
51,437,829.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
167,384,986.87 |
| Total Liabilities |
1,959,922,732.70 |
| Paid-In Capital(Or Share Stock) |
380,633,100.00 |
| Capital Surplus |
1,349,830,425.81 |
| Surplus Reserve |
114,032,785.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,040,633,099.01 |
| Minority Stockholder's Interest |
2,799,549.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,896,196,179.79 |
| Owner's Equity（Stockholder's Equity） |
2,898,995,729.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,858,918,462.33 |
